Candel Therapeutics, Inc. (CADL): Shares Outstanding
54.90M
As of 2025-12-31
76.12M
As of 2026-06-30
+23.8%
3-year compound annual growth
+36.4%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 54.90M | +17.3% | 2026-03-12, Balance as of period end |
| 2024-12-31 | 46.81M | +60.9% | 2026-03-12, Balance as of period end |
| 2023-12-31 | 29.09M | +0.6% | 2025-03-13, Balance as of period end |
| 2022-12-31 | 28.92M | +0.8% | 2024-03-28, Balance as of period end |
| 2021-12-31 | 28.69M | +146.6% | 2023-03-30, Balance as of period end |
| 2020-12-31 | 11.64M | n/a | 2022-03-29, Balance as of period end |